30
Kiel MJ, Morrison SJ (2008) Uncertainty in the niches that maintain haematopoietic stem cells.
Nat Rev Immunol 8:290–301
Koh MY, Spivak-Kroizman T, Venturini S, Welsh S, Williams RR, Kirkpatrick DL et al (2008)
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-
inducible factor-1alpha. Mol Cancer Ther 7:90–100
Korn C, Méndez-Ferrer S (2017) Myeloid malignancies and the microenvironment. Blood
129:811–822
Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D et al (2013) Arteriolar niches
maintain haematopoietic stem cell quiescence. Nature 502:637–643
Kuschel A, Simon P, Tug S (2012) Functional regulation of HIF-1α under normoxia--is there more
than post-translational regulation? J Cell Physiol 227:514–524
Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M et al (2013) BCL-2
inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leuke-
mia stem cells. Cell Stem Cell 12:329–341
Lane SW (2012) Bad to the bone. Blood 119:323–325
Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J (2000) Bone marrow in
polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascular-
ity. Am J Pathol 157:15–19
Medinger M, Skoda R, Gratwohl A, Theocharides A, Buser A, Heim D et al (2009) Angiogenesis
and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms:
correlation with clinical parameters and JAK2-V617F mutational status. Br J Haematol
146:150–157
Mendelson A, Frenette PS (2014) Hematopoietic stem cell niche maintenance during homeostasis
and regeneration. Nat Med 20:833–846
Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA et al (2010)
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature
466:829–834
Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, Järås M, Puram RV et al (2013) In Vivo RNAi
screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell
24:45–58
Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem cells. Nature
505:327–334
Mussai F, De Santo C, Abu-Dayyeh I, Booth S, Quek L, McEwen-Smith RM et al (2013) Acute
myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.
Blood 122:749–758
Nervi B, Ramirez P, Rettig MP, Uy GL, Holt MS, Ritchey JK et al (2009) Chemosensitization of
acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
Blood 113:6206–6214
Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT et al (2005)
Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive
hematopoietic progenitor cells. Blood 106:1232–1239
Nombela-Arrieta C, Pivarnik G, Winkel B, Canty KJ, Harley B, Mahoney JE et al (2013)
Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic sta-
tus in the bone marrow microenvironment. Nat Cell Biol 15:533–543
Nwajei F, Konopleva M (2013) The bone marrow microenvironment as niche retreats for hemato-
poietic and leukemic stem cells. Adv Hematol 2013:953982
Price T, Sipkins DA (2014) Rewiring the niche: sympathetic neuropathy drives malignant niche
transformation. Cell Stem Cell 15:261–262
Prowse AB, Chong F, Gray PP, Munro TP (2011) Stem cell integrins: implications for ex-vivo
culture and cellular therapies. Stem Cell Res 6:1–12
Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF et al (1999) Angiogenesis
in myelodysplastic syndromes. Br J Cancer 81:1398–1401
Y. Tabe and M. Konopleva